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ABSTRACT
Purpose: Renal scintigraphy has been used for many years in the evaluation of renal transplants
and can help in the diagnosis of graft complications, leading to prompt clinical management and pre-
venting further deterioration of renal function. The purpose of this study was to evaluate the overall
accuracy of renal scintigraphy with 99mTc-DTPA in the diagnosis of acute renal graft complications.
Materials and Methods: Seventy-six scintigraphic studies performed in 55 patients (ages
ranging from 6 to 65 years), were reviewed. Scintigraphy results were compared to biopsies performed
within 5 days of imaging. 99mTc-DTPA study was performed within a mean time of 19 days after
kidney transplants. Dynamic images were performed in the anterior position of the abdomen and
pelvis every 2 seconds for 80 seconds (flow phase) and every 15 seconds for 30 minutes (functional
phase), after an intravenous injection of 370 MBq (10 mCi) of 99mTc-DTPA.
Results: The scintigraphic results were concordant with the biopsies in 86% of the cases studied.
The sensitivities of renal scintigraphy for detection of acute tubular necrosis (ATN), acute rejection
(AR) and cortical necrosis (CN) were 98%, 87% and 100%, respectively. Specificities and accuracies
for detection of ATN, AR and CN were 89%, 86% and 100%, and 95%, 87% and 100%, respectively.
Conclusion: Renal scintigraphy with 99mTc-DTPA showed a good overall accuracy in the
detection of acute renal graft complications. It can be used as a reliable tool in the routine evaluation
of these patients.
Key words: kidney; kidney transplantation; radionuclide imaging; graft rejection; diagnosis
Int Braz J Urol.  2003; 29: 507-516
INTRODUCTION
Renal scintigraphy is one of the most fre-
quently used methods in the evaluation of renal al-
lograft dysfunction (1-4) along with other diagnostic
tests, such as clinical criteria, ultrasound, serum crea-
tinine levels, fine needle aspiration biopsy, magnetic
resonance imaging and core biopsy, helping in the
identification of acute and long term complications
(5-7). The most common renal transplant complica-
tions are acute tubular necrosis, rejection (hyperacute,
accelerated, acute, chronic), cyclosporin toxicity,
urine leak, hematoma, obstruction, lymphocele and
renal artery stenosis.
Nuclear medicine plays an important role in
the investigation of renal graft complications and sev-
eral radiopharmaceuticals can be employed (8). Rou-
tinely, 99mTc-DTPA and 99mTc-MAG3 are used, al-
though studies with 131I-OIH, 99mTc-GHA, Ga-67,
99mTc-sulfur colloid, radiolabeled leukocytes and
platelets have also been performed (9-11). The scin-
tigraphic evaluation of the transplanted kidney in-
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volves qualitative or quantitative analysis of the 3
phases of renal scintigraphy: the flow phase, the func-
tional phase and the excretion phase (4,12). 99mTc-
DTPA can be very helpful in the evaluation of dys-
functional kidneys, since it has a reasonable extrac-
tion rate and a low cost.
Biopsy, the gold standard for the detection of
renal graft non-surgical complications, is an invasive
procedure that carries a higher morbidity when com-
pared to non-invasive diagnostic tests such as renal
scintigraphy. Ideally, its use should be restricted to
patients in whom non-invasive procedures are inde-
terminate.
The purpose of this study was to determine
the accuracy of dynamic renal scintigraphy with 99mTc-
DTPA in the identification of acute renal graft com-
plications, when compared to core biopsy.
MATERIALS AND METHODS
Patient Selection
Seventy-six scintigraphic studies performed
in 55 patients were reviewed. 99mTc-DTPA study was
performed 1 day to a maximum of 6 months (mean
19 days) after kidney transplants (cadaveric or living
donors).
Patients’ ages ranged from 6 to 65 years
(mean 37 years), 38 were males (69%) and 49 (89%)
were recipients from cadaveric donors.
As part of the approach to transplanted
patients in our medical institution, they would
undergo renal scintigraphy routinely within the first
24 hours after surgery as a baseline study. Studies
were repeated whenever complications were
suspected, so as biopsies did, whenever clinically
indicated. All patients in this study were
retrospectively collected when performed 99mTc-
DTPA scintigraphy and core biopsies within a
maximum time interval of 5 days between the two
procedures.
Other diagnostic methods such as urinary
outflow, creatinine levels, and Doppler ultrasound
were performed whenever necessary but not taken
into analysis since it is not the aim of the present
study.
Renal Scintigraphic Studies
Patients received an intravenous injection of
370 MBq (10 mCi) of 99mTc–DTPA and sequential
images in the anterior position of the abdomen and
pelvis, every 2 seconds for 80 seconds (flow phase)
and every 15 seconds for 30 minutes (functional
phase) were begun immediately after injection.
Additional hydration prior to the study was
not addressed in the early days after transplantation
since we did not want to interfere in the water balance
of the patients. Later, as long as no restrictions advised
by the referring physician, oral hydration with 500 to
600 ml of water was given 30 minutes before the
study.
Images were obtained on a camera-computer
system equipped with a LEAP collimator.
The flow and functional phases were
analyzed visually. Time-activity curves were also
obtained from regions of interest (ROI) drawn over
the grafted kidney and the aorta, subtracting the
background activity.
Imaging Interpretation
Three experienced nuclear medicine
physicians blindly interpreted the scintigraphies.
Scintigraphic criteria were pre-established and then
compared to the biopsy findings.
The blood flow phase was analyzed
predominantly qualitatively using the aorta or the iliac
arteries as references. Renal graft blood flow was
considered normal when the peak kidney activity,
within 6 seconds of the peak aorta or iliac activity,
was equal to or higher than that of the peak aorta or
iliac artery activity. Mildly, moderately and severely
decreased flow was considered as so according to the
severity of the flow reduction on the visual analysis
as well.
Interpretation of the functional phase was also
performed qualitatively, evaluating the images and
quantitatively, evaluating the renogram curves. This
evaluation included the accumulation phase, in which
the extraction of the tracer from the blood during the
first 3 minutes was evaluated; the concentration phase,
in which the capacity of concentrating urine (water
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absorption) was analyzed; and the excretion phase,
in which the transit of the radiopharmaceutical from
the collecting system to the bladder was evaluated.
According to the scintigraphic findings in the
flow and functional phases, the studies were classified
as probable acute tubular necrosis (ATN), acute
rejection (AR), cortical necrosis (CN), cyclosporin
toxicity (CyT) and the association of ATN with AR
(ATN + AR).
Scintigraphic Criteria
ATN - Normal or mildly decreased blood
flow; normal or mildly decreased accumulation of the
tracer, with a more prominent impairment of the
concentration and excretion phases (difficulty in
progression of the tracer in the damaged tubules)
(Figure-1).
AR - Moderately or severely decreased blood
flow and function or significantly decreased renal
blood flow and function when compared to a previous
study if available (Figure-2).
CN - Absence of blood flow and function,
the location of the graft depicted as a photopenic area
(Figure-3).
CyT - Scintigraphic pattern similar to ATN.
Usually occurs after 30 days after the introduction of
the drug, a period during which the impairment in
renal function caused by ATN is expected to have
subsided.
ATN + AR - Decreased flow and function in
the follow up studies of patients with previously
detected ATN.
Histopathological Analysis
Core biopsy specimens were reviewed by an
experienced pathologist according to the Banff 97
criteria (13), using a 0 – 3 + semi quantitative scale
for each of the following histopathologic findings:
acute glomerulitis, lymphocytic tubulitis, interstitial
inflammation, vasculitis, chronic transplant
glomerulopathy, interstitial fibrosis, tubular atrophy,
and fibrointimal thickening. Evidence for possible
Figure 1 – Renal scintigraphic study with 99mTc-DTPA of a patient with acute tubular necrosis. A) Flow phase. Note the normal flow to
the graft. B) Functional phase. There is mildly reduced accumulation of the radiotracer and moderate reduction of the concentration
and excretion of the radiopharmaceutical. A rim of reduced radioactivity is noted, peripheral to the kidney, mainly on its lateral border
and is due to an hematoma.
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Figure 2 – Renal scintigraphic study with 99mTc-DTPA of a patient with acute rejection. A) Flow phase. Note the moderate reduction of
the flow to the graft. B) Functional phase. There is moderately reduced accumulation, concentration and excretion of the radiotracer.
drug toxicity was also recorded.  Based on these
findings, the biopsies were classified as ATN, AR,
ATN + AR, CN, CyT.
Statistical Analysis
The diagnostic value of scintigraphy was
expressed as sensitivity (St), specificity (Sp), positive
predictive value (PPV), negative predictive value
(NPV) and accuracy (A) for the diagnosis of ATN,
AR and CN. Biopsy was considered the gold standard
for comparison.
RESULTS
The scintigraphic and biopsy results were
compared and classified as concordant or discordant
(Table-1).
Scintigraphy identified 27 ATN, 45 AR and
4 CN events. Core biopsy identified 24 ATN, 47 AR,
4 CN and 1 CyT events. Table-2 shows that 66
diagnoses (87%) were concordant and 10 (13%) were
discordant (Figure-4).
Among the 10 discordant studies, in 6
scintigraphy failed to demonstrate AR detected by
biopsy. In 4 cases, DTPA-99mTc scintigraphy was
interpreted as AR but biopsy showed only ATN in 3
cases and CyT in the remainder.
Sensitivity, specificity, positive predictive
value, negative predictive value and accuracy of
DTPA-99mTc scintigraphy for the diagnosis of ATN,
AR and CN are displayed in Table-3. The overall
accuracy of scintigraphy for the most important and
severe complications was high (87% for AR, 95%
for ATN and 100% for CN) with good specificity
(86% for AR, 89% for ATN and 100% for CN).
DISCUSSION
Acute or chronic rejection is a main concern
in the follow-up of transplanted patients since it can
lead to graft dysfunction and loss. Most methods used
in the evaluation of graft complications are aimed at
the early diagnosis of rejection. The most frequently
available non-invasive methods are serial serum
creatinine levels, creatinine clearance, ultrasound
(with or without Doppler scanning), renal scintigraphy
(mainly with 99mTc-DTPA and 99mTc-MAG3), magnetic
resonance imaging, urinary cytology, and serum and
immunologic markers. Invasive procedures include
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Figures 3 –  Renal scintigraphic study with 99mTc-DTPA of a patient with cortical necrosis. A) Flow phase. Note absence of flow to the
graft, located in the left iliac fossa. B) Functional phase. There is no accumulation or concentration of the radiotracer in the graft. This
indicates a complete functional loss of the graft.
Figure 4 – Correlation between scintigraphy and biopsy results.
intrarenal manometry, fine-needle aspiration biopsy
(FNAB) and core biopsy, considered the definitive
procedure for precise characterization of graft
complications.
Accurate non-invasive diagnostic methods at
a lower cost are the preferred techniques to be used.
Delaney et al. (14) compared FNAB, Doppler
ultrasound and radionuclide scintigraphy for the
detection of renal graft complications and also
performed a cost analysis. Scintigraphy was the most
sensitive method for detection of acute rejection (70%
overall), while FNAB and Doppler ultrasound had
sensitivities as low as 52% and 43%, respectively.
The cost of radionuclide scintigraphy was not
considered ideal (only 9% lower than core biopsy).
In their study, FNAB not only had a low sensitivity,
but also was insufficient for diagnosis of renal graft
complications in approximately 13% of cases.
Hall et al. (15) also compared radionuclide
scintigraphy and ultrasound without Doppler to
biopsy findings, including the severity of cell
infiltration. When performed within 48 hours of
biopsy with heavy mononuclear interstitial cell
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Pt            Age(yrs)       TT (days)
      ∆t (days) Scintigraphic Findings     BIOPSY  Analysis
 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
25
44
25
24
36
28
45
55
29
18
28
46
23
44
25
30
28
13
30
37
65
35
30
44
30
25
40
38
38
41
8d
7
2
9
30
6
19
5
1
5
7
12
4
8
9
31
7
28
42
55
13
10
8
20
10
17
12
23
8
19
33
49
6
9
2
30
36
1
1
23
150
2
17
4
0
2
4
0
3
2
3
1
5
5
0
1
3
2
1
5
4
5
0
5
1
1
0
1
2
1
3
2
2
3
5
5
0
2
5
2
0
4
5
5
0
4
5
4
 AR
ATN + AR
ATN + AR
ATN + AR
ATN
AR
AR
ATN
ATN
ATN
ATN
ATN
ATN
ATN + AR
ATN
AR
ATN
ATN
ATN + AR
ATN + AR
ATN
AR
ATN + AR
AR
ATN + AR
ATN + AR
AR
ATN + AR
ATN + AR
AR
AR
AR
ATN
ATN + AR
ATN
ATN + AR
ATN
ATN
ATN
AR
ATN
ATN
ATN
ATN + AR
AR
ATN + AR
ATN + AR
ATN + AR
ATN
AR
AR
ATN
ATN
ATN
ATN
ATN
ATN
ATN + AR
ATN
AR
ATN
ATN
ATN + AR
ATN + AR
ATN
AR
ATN + AR
AR
ATN + AR
ATN + AR
AR
ATN + AR
ATN + AR
AR
AR
CyT
ATN + AR
ATN + AR
ATN
ATN + AR
ATN
ATN + AR
AR
ATN
ATN
ATN
ATN
ATN + AR
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
D
D
C
C
C
C
D
D
D
C
C
C
C
Table 1 – General data.
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Pt            Age(yrs)      TT (days)
     ∆t (days)       Scintigraphic Findings   BIOPSY              Analysis
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
20
31
50
47
18
37
46
29
14
14
47
39
23
24
29
26
20
6
26
51
59
33
52
35
13
43
7
6
13
20
4
120
12
10
32
44
5
29
32
7
14
5
10
16
7
14
13
5
8
28
41
32
11
15
12
9
32
2
3
5
1
1
2
2
0
1
3
1
2
0
2
1
2
2
5
1
0
0
4
0
1
0
0
5
1
4
0
3
4
AR
ATN
ATN
AR
AR
ATN
ATN
CN
ATN
AR
AR
ATN + AR
AR
ATN
ATN + AR
ATN + AR
ATN + AR
AR
ATN
ATN + AR
ATN + AR
ATN + AR
CN
ATN + AR
AR
ATN + AR
ATN
CN
AR
ATN + AR
CN
ATN + AR
AR
ATN
ATN
AR
AR
ATN + AR
ATN
CN
ATN
AR
AR
ATN + AR
AR
AR
ATN + AR
ATN + AR
ATN + AR
AR
AR
ATN + AR
ATN + AR
ATN + AR
CN
ATN + AR
AR
ATN + AR
ATN
CN
AR
ATN
CN
ATN
C
C
C
C
C
D
C
C
C
C
C
C
C
D
C
C
C
C
D
C
C
C
C
C
C
C
C
C
C
D
C
D
Table 1 – General data. (- continued)
Pt = patient; TT= time after kidney transplant; ∆t = time between scintigraphy and biopsy; C = Concordant; D = Discordant;
ATN = acute tubular necrosis; AR = acute rejection; CyT = cyclosporine nephrotoxicity; CN= cortical necrosis.
infiltration, radionuclide scintigraphy had a sensitivity
of 96% for the detection of acute rejection while the
sensitivity of ultrasound was only 21%. Nevertheless,
the specificity of scintigraphy was low, 54%.
Sensitivity of radionuclide scintigraphy was low in
cases with mild or no interstitial cell infiltration, but
was still better than that of ultrasound (6/13 patients
versus 0/4 patients, respectively). The radionuclide
scintigraphy study frequently contributed to the final
diagnosis particularly when the biopsy findings were
inconclusive or the patient responded to therapy,
consistent with the radionuclide scintigraphy findings.
Consequently, the final diagnosis was not always
“independent” of the radionuclide scintigraphy
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Table 2 –  Correlation of the most frequent findings of scintigraphy and biopsy.
                                                                                               Biopsy
       ATN              AR                    ATN + AR          CN
ATN          21                3                             3             0
AR            1              18                             0             0
ATN+AR            2                0                           23             0
CN            0                0                             0             4
Total          24              21                           26             4
ATN = acute tubular necrosis; AR = acute rejection; CN = cortical necrosis.
Sc
in
tig
ra
ph
y
Table 3 –  Diagnostic value of scintigraphy.
ATN AR CN
Sensitivity 98% 87% 100%
Specificity 89% 86% 100%
PPV 94% 91% 100%
NPV 96% 81% 100%
Accuracy 95% 87% 100%
PPV  = positive predictive value; NPV  = negative predictive
value; ATN = acute tubular necrosis; AR = acute rejection;
CN = cortical necrosis.
results. In their experience, a biopsy finding with
heavy cellular infiltration was the most reliable
independent factor for the diagnosis of acute rejection.
Akhtar et al. (16) also reported low sensitivity
and specificity of ultrasound and Doppler ultrasound.
They found that an increase in the resistivity index
greater than 0.7 was present in 31.5% of AR but was
also elevated in 26.7% of CyT and in 44.4% of ATN.
Aktas et al. (17) reported Doppler ultrasound
sensitivities as low as 45% for low-grade rejections
(based on Banff criteria) and as high as 88% for high-
grade rejections. Surprisingly, the same sensitivities
were found for radionuclide scintigraphy when altered
perfusion alone was considered. When the analysis
included also altered concentration and retention of
the radiopharmaceutical, sensitivity of scintigraphy
increased to 64% and 100% for low and high grade
rejection, respectively, which is still lower than in
other reports.
The most frequent complications found in the
present study (ATN, AR and CN) were those expected
to occur in the early acute phase post transplant, when
this population was analyzed (first 3 weeks after
surgery).
Radionuclide scintigraphy failed to detect
acute rejection in 6 of the 76 studies (8%). On the
other hand, in 3 patients in whom radionuclide
scintigraphy showed AR with negative biopsies, the
clinical follow-up confirmed rejection by
improvement in renal function after systemic
treatment with immunosuppressive drugs or new
biopsies performed a few days later. False-negative
biopsies can occur, since the fragment removed may
not always be representative of the entire
histopathological process and AR most commonly
happens in multiple focal areas. The overall accuracy
of core biopsy has been reported to be about 91%
(18,19).
If the false-positive cases of AR were
compared to clinical outcome instead of biopsy
results, the specificity and accuracy of radionuclide
scintigraphy for the diagnosis of AR in the current
study would increase to 96% and 91%, respectively.
Detection of ATN was also efficient in the
present group of patients (98%), coupled with a
specificity of 95%. Cófan et al. (20) assessed the value
of dynamic radionuclide scintigraphy for the detection
of ATN with 99mTc-MAG3 compared to Doppler
ultrasound in 45 patients with ATN. The authors
concluded that Doppler ultrasound does not
discriminate the ATN severity and a resistivity index
= 1 in the baseline study could not be related to a
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worse prognosis. Nevertheless, severe ATN was
associated with prolonged dialysis treatment and
reduced graft survival.
Although the number of cortical necrosis
events was small (4 cases) in the present study, the
high accuracy achieved was expected to happen, since
the alteration in flow and function of the graft is
dramatic. In the present study there was only a single
case of CyT, thus, it was not possible to estimate a
reasonable value for the diagnostic accuracy of
radionuclide scintigraphy for the diagnosis of this
complication and CyT is typically a late complication
of the transplant.
The high values of sensitivity, specificity and
overall accuracy for the most frequent early graft
complications in this series of renal transplants can
be explained because all the patients analyzed had a
previous scintigraphy study in the first 24 hours post
surgery (baseline study), and also because the nuclear
medicine physicians were not blind to the clinical data
and that a baseline study is routinely performed,
preferably in the first post operative day, for
comparison.
Khajehmugehi et al. (18) concluded after
reviewing 230 episodes of AR in renal transplant
recipients, that although the most sensitive (91%) way
to diagnose AR was kidney biopsy, “the best mode of
diagnosing rejection was DTPA isotope scanning.”
However, only the kidney biopsy can give the
diagnosis and severity of the acute rejection,
especially in cases when ATN is associated with
rejection or in presence of a vascular component of
rejection.
CONCLUSIONS
99mTc-DTPA scintigraphy is a safe,
noninvasive and easy-to-perform method that has
shown a good correlation with biopsy results and
clinical evolution of renal transplanted patients.
We have a strong belief that the best approach
in clinical practice to aid in the correct diagnosis of
graft complications is to routinely perform a baseline
99mTc-DTPA study as screening, preferably in the first
post transplant hours, which is useful for further
comparison, improving the accuracy of this method.
Gathering all these data and using biopsy to confirm
diagnosis, leads to prompt intervention when
necessary.
The early detection of severe graft
complications such as rejection, vascular thrombosis
or graft necrosis will lead to their prompt treatment,
reducing the risks of further kidney damage or of
complications derived from the presence of a non-
viable graft.
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